Following a solid performance in Q2, Boston Scientific raised its full year outlook for sales to increase 19-20% and adjusted earnings to be in the range of $1.58-$1.62 per share.
Source: Forbes Markets
Following a solid performance in Q2, Boston Scientific raised its full year outlook for sales to increase 19-20% and adjusted earnings to be in the range of $1.58-$1.62 per share.
Source: Forbes Markets
